ReviewPublished 12 October 2026Botanical polysaccharides as veterinary vaccine adjuvants: structure, receptors, and translational limitsRan Guan · Chaoyun YangFrontiers in Immunologydoi 10.3389/fimmu.2026.1982641
ReviewPublished 1 October 2026Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~Kazuaki Mori · Yoshihito Nihei · Yusuke SuzukiFrontiers in Nephrologydoi 10.3389/fneph.2026.1977707
ReviewPublished 4 June 2026Porcine rotavirus type A VP8 protein: an antigen with dual functions as a subunit vaccine and serological diagnostic agent, from receptor binding to mucosal and systemic immunityZhang Zhen · Liu Shuhua · Ma Baihe · Chen Xin · Guo Meiliang · Liang Fanxin · Li LianruiFrontiers in Virologydoi 10.3389/fviro.2026.1859126
CorrectionPublished 22 May 2026Correction: Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic VirusErnesto de Bernardis · Fabio Lugoboni · Lina Busà · Giulio Petronio Petronio · Roberto Di MarcoFrontiers in Virologydoi 10.3389/fviro.2026.1840666
PerspectivePublished 27 March 2026Re-opening the question of lower SARS-CoV-2 attack rates in active smokers: a perspective on viral interference and Tobacco Mosaic VirusErnesto de Bernardis · Fabio Lugoboni · Lina Busà · Giulio Petronio Petronio · Roberto Di MarcoFrontiers in Virologydoi 10.3389/fviro.2026.1801380
MalariaPublished 25 June 2025Targeting mucosal immunity in malaria control: the underexplored role of IgAHaruna Muwonge · Isaac Ssewanyana · Adoke Yeka · Pauline Byakika-KibwikaFrontiers in Malariadoi 10.3389/fmala.2025.1557371
